S T S Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-01-2025
- Paid Up Capital ₹ 3.00 M
as on 07-01-2025
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 455.40%
(FY 2023)
- Profit 122.96%
(FY 2023)
- Ebitda 150.98%
(FY 2023)
- Net Worth 17.03%
(FY 2023)
- Total Assets 108.84%
(FY 2023)
About S T S Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Yashaswini and Basavarachachari Yogesh serve as directors at the Company.
- CIN/LLPIN
U74220KA2020PTC141264
- Company No.
141264
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2020
- Date of AGM
23 Oct 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does S T S Biotech Private Limited offer?
S T S Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Fish Foods, Poultry Feed.
Who are the key members and board of directors at S T S Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Yashaswini  | Director | 20-Nov-2020 | Current |
| Basavarachachari Yogesh | Director | 20-Nov-2020 | Current |
Financial Performance of S T S Biotech.
S T S Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 455.4% increase. The company also saw a substantial improvement in profitability, with a 122.96% increase in profit. The company's net worth Soared by an impressive increase of 17.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S T S Biotech?
Unlock access to S T S Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at S T S Biotech?
S T S Biotech has a workforce of 2 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S T S Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S T S Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
